Aurisco Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is FINERENONE, with a corresponding US DMF Number 40497.
Remarkably, this DMF maintains an Active status since its submission on October 29, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 13, 2024, and payment made on November 12, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II